TYROSINE KINASE INHIBITOR
Clinical trials for TYROSINE KINASE INHIBITOR explained in plain language.
Never miss a new study
Get alerted when new TYROSINE KINASE INHIBITOR trials appear
Sign up with your email to follow new studies for TYROSINE KINASE INHIBITOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo shows promise for Hard-to-Treat lung cancer
Disease control CompletedThis study tested a combination of two drugs—bevacizumab and a higher dose of icotinib—in 35 people with advanced non-squamous lung cancer that has a specific EGFR mutation (L858R). The goal was to see if the combo could delay cancer growth better than standard treatment. Partici…
Matched conditions: TYROSINE KINASE INHIBITOR
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
Liver cancer patients: do Pre-Transplant drugs improve outcomes?
Knowledge-focused CompletedThis study looked back at data from 484 liver cancer patients who had a liver transplant. Researchers wanted to see if taking certain cancer drugs (tyrosine kinase inhibitors) before the transplant helped patients live longer or kept the cancer from coming back. The goal was to f…
Matched conditions: TYROSINE KINASE INHIBITOR
Sponsor: Hu Liangshuo • Aim: Knowledge-focused
Last updated May 26, 2026 12:08 UTC